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IN TRO D U CTIO N
Enteroviruses, together with the rhinoviruses, aphtho- 
viruses, and the cardioviruses, belong to  the family of 
Picomaviridae1 The genus enterovirus can be further 
divided into polio-, ECHO-, Coxsackie A  and B-, 
and the enteroviruses 68 to  71.
Enteroviruses are the prototype of positive-strand 
RNA viruses since the genome is similar to  eukaryotic 
mRNA. A  small virally encoded protein, Vpg, is 
covalently attached to  the 5 'end and a poly(A) tail is 
present at the 3 'end of the viral RNA. Once the virus has 
entered the host cell, uncoating is completed and the viral 
RNA is released into the cytoplasm of the cell where the 
RNA is directly translated into a polyprotein1 of M r 
about 200 000. Directly after infection, host cell protein 
synthesis is shut-off. Evidence for the mechanism of 
poliovirus shut-off points towards the inactivation of 
initiation complex elF—4F, in which the cleavage of a 
cellular protein p220 by the 2A protease is thought to be 
involved.2
Virus progeny are released by cell-Iysis which is 
induced by the infection itself. The virus can subse­
quently spread throughout the body until neutralising 
antibodies arise that stop further spreading and eliminate 
the virus. A t that point, virus cultures will become 
negative. The role of cellular immunity seems to  be of 
less importance than that of antibody. This is consistent 
w ith an obligatory cell-lysis forming part of the in vivo 
infectious cycle. Thus, chronic enterovirus infections are 
only known to occur in patients w ith agammaglobuli- 
naemia3 or neonates, in whom  the immune system is still 
immature.4 It is possible to  isolate virus from such 
patients, even in the chronic stage of the infection. In 
normal health, enteroviral infection may follow a biphasic 
course, with a secondary viraemia with dissemination of 
the infection to  target organs such as heart, brain, 
pancreas, or muscle.5
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Chronic inflammatory diseases such as polymyositis 
and chronic myocarditis are also associated with 
enteroviral infections. These diseases are regarded as 
autoimmune diseases, possibly induced by a preceding 
enteroviral infection. In the past decade, however, several 
papers have been published which describe the detection 
of enteroviral RNA in skeletal and heart muscle of such 
patients. These findings suggest that the virus persists 
after the acute phase of infection and that the virus itself 
may actually predispose to  the maintenance of disease. 
These diseases, however, have in common that the virus 
itself can not be isolated anymore. Persistence of 
enterovirus has also been claimed for several other 
diseases as the post viral fatigue syndrome, insulin­
dependent diabetes mellitus, and the post-polio syn­
drome. Enteroviral persistence has been dem onstrated 
in oitro. However, as in the case of enteroviral persistence 
in neonates and patients w ith agammaglobulinaemia, 
these are chronic productive infections. This is in contrast 
to  enteroviral persistence as supposed to  occur in the 
diseases as m entioned above, in which no virus can be 
isolated, and in which only the viral RNA has been 
found. The following paragraphs will review the litera­
ture associating enterovirus infections w ith several 
chronic medical conditions, to  investigate whether there 
is indeed evidence for enteroviral persistence in these 
diseases.
Idiopathic dilated cardiomyopathy
In idiopathic dilated cardiom yopathy (IDC), the heart 
chambers are dilated. The aetiology of this disease is 
unknown. Incidences of 5 to  10 cases per 100 000 people 
per year have been reported from the USA and 
Sweden.6'7 The disease has a variable clinical course 
w ithout useful prognostic markers. As a result, it has been 
difficult to  evaluate the effect of medication and the only 
effective therapy for end-stage disease is heart transplan­
tation. In fact, it is the second m ost common reason for 
cardiac transplantation in the UK.8
Epidemiological studies revealed that enterovirus 
(mainly Coxsackie B) is one of the m ost important 
causitative agents of acute myocarditis.9 It is thought that
Accepted 7 October 1993
236 FORUM
Table 1. Molecular detection of enteroviral RNA in chronic diseases
Reference Country Method Disease
Number of 
patients
Enteroviral
positive
Bowles et a/.1131 UK QSB IDC 21 6
Control 19 1
Bowles et a/.1141 UK QSB IDC 8 5
Myoca 9 4
Control 5 0
Archard et a/.1151 UK QSB IDC 29 16
Myoca 21 12
Control 22 0
Wiegand el a/.1101 G/USA DS IDC 6 1
Control 8 0
Cochrane et al.1171 UK NB IDC 19 0
Control 21 0
Kandolf et al}1<>I G ISH IDC
recent 33 10
chronic 48 8
Myoca 62 13
Control 53 0
Weiss et USA PCR IDC 11 0
Myoca 5 1
Control 21 0
Weiss et a/.1’01 USA PCR IDC 11 5
Control 24 9
Zoll el a/.1211 NL PCR IDC 5 1
Control 8 0
Petitjean et a/.1221 F PCR IDC 45 30
Myoca 10 3
Control 23 9
Grasso el a/.12' 1 I PCR IDC 21 0
Control 20 0
Jin et a/.1’41 USA PCR CMP 23 4
Myoca 25 1
Keeling et a/.1251 UK PCR IDC 50 6
Control 75 13
Liljeqvist et al.12“1 S PCR IDC 35 0
Control 23 0
UK. United Kingdom; G. Germany; USA, United States of America; NL, Netherlands; F, France; I, Italy; QSB, Quantitative slot-blot: 
DS. Dot-spot; NB, Northem-blot; ISH, lit si'fn hybridisation: PCR. Polymerase chain reaction; 1DC, Idiopathic dilated cardiomyopathy; 
Myoca, Myocarditis; CMP. Cardiomyopathy.
IDC may be a late outcome of viral myocarditis.10 It is 
also assumed that IDC develops after the virus has been 
eliminated, and therefore it is suggested that the virus 
triggers an autoimmune response.11,12 O ver the past few 
years it has been suggested that enteroviruses are able to 
persist and that persistence could play a role in the 
aetiology of myocarditis and IDC. The data are sum­
marised in Table 1. D etection of viral RNA in specimens 
from patients, while the virus itself can no longer 
be isolated, led investigators to  suggest that the viral 
RNA persists in some patients and predisposes to  the 
maintenance of disease.
A lthough enteroviral RNA could be detected in car­
diac biopsies from patients w ith myocarditis (20%—50%) 
or IDC (0%— 75%), the incidence of positive patients
varies significantly betw een the different studies. In situ  
hybridisation (ISH) studies revealed that the enteroviral 
infection has a highly focal character.27 Since, in practice, 
only few (or even one single) biopsies are tested per 
patient for enteroviral RNA detection, sampling error can 
explain part of the variation. However, this is not the 
most plausible explanation since m ost studies have used 
explanted hearts, which contain enough material for 
reliable determination.
The molecular m ethod which was used for the 
detection of enteroviral RNA varies from study to study 
(Table 1). Kandolf et a l.16 used ISH with enteroviral 
probes and detected enteroviral RNA in 22% of the 
patients with IDC. Cronin et al.28 reported that slot-blot 
hybridisation sometimes revealed unexplained strong
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hybridisation signals and that slot-blot hybridisation is 
less reliable than ISH. It can therefore not be excluded 
that the results, obtained by slot-blot hybridisation, are at 
least in part caused by cross-hybridisation w ith unrelated 
sequences. PCR is considered to  be the m ost sensitive 
technique for the detection of enteroviruses today.29 
Furthermore, the selection of highly specific primers and 
oligonucleotide probes will result in a specific amplifica­
tion of enteroviral target sequences. It has indeed been 
shown that PCR is m ore specific than slot-blot hybridis­
ation.24 Using PCR, several groups19'23'26 failed to detect 
enteroviral RNA in biopsy samples from patients with 
IDC, while Petitjean et a l22 found 75% of the patients 
with IDC positive for enteroviral RNA. The results of 
Weiss et al,19 may be explained by the fact that they only 
used a coxackievirus B3 specific PCR assay, which implies 
that they may have missed other enterovirus serotypes 
possibly involved in the disease. In fact, very recently, 
the same authors described a 45% positivity rate in 
patients w ith IDC using highly conserved enterovirus 
specific primers, although they also detected enteroviral 
RNA in 38% of the control specimens.20 Petitjean et al.22 
also found 39% of the control group (i.e. patients with 
cardiomyopathy w ithout viral aetiology) positive for 
enteroviral RNA, possibly indicating that the presence of 
enteroviral RNA in heart muscle tissue is more common 
than has been appreciated. Similar findings are reported 
by Keeling ei al.,25 w ho also described a similar preva­
lence of enteroviral RNA in control patients (17%) and 
patients with IDC (12%), and suggested that entero­
viruses are common infectious agents rather than the 
causative agents of IDC. The fact that enterovirus seems 
to  be common in heart muscle is also described by Easton 
and Eglin,30 who detected enteroviral RNA in 46% of the 
myocardial biopsies from a selected group of patients 
with proven coxsackievirus B infection at the time of 
death.
Various animal models have been described of 
picomavirus induced myocarditis,31 of which the murine 
model of coxackievirus B3 induced myocarditis is the 
most extensively studied. This model resembles the 
human disease in that chronic inflammation of heart tissue 
can often be observed for m onths after infection. Klingel 
ei al.32 described an ongoing myocarditis in this murine 
model related to  the persistence of coxsackievirus B3. 
A lthough the virus could not be isolated after 15 days 
p.i., the viral RNA could still be detected up to 30 days 
p.i. by ISH. It was suggested that the enteroviral RNA 
can persist and contribute to the maintenance of 
disease.32-34 Immune-mediated processes may be trig­
gered and maintained by enteroviral RNA persistence 
and the viral RNA might not be eliminated after initiation 
of the disease. However, in the acute phase of disease 
13% of the myocardial cells were found to be infected, 
while at day 30 p.i., only 0-01% of the myocardial cells 
were found positive for enteroviral RNA. Koidi ei al.35 
detected enteroviral RNA up to day 28 after inoculation. 
They describe a decreasing number of positive animals 
w ith time so that by day 28, the virus could no longer be 
detected in myocardial cells. Similar results have been
described by Cronin et al.26 Using an encephalomyo- 
carditis virus-induced myocarditis (and myositis) murine 
model, infectious virus could be isolated up to  2 weeks 
p.i. The viral RNA could, however, be demonstrated by 
ISH for up to 3 weeks but not thereafter. These data 
together support the idea that the infection is dying out, 
rather than persisting. Jin et al.24 described a case of a 
patient w ith myocarditis, positive for enteroviral RNA by 
PCR, who was found again positive 3 m onths later. A 
third biopsy, 4 m onths thereafter was, however, negative. 
This could be explained either by sampling error or 
by the fact that the viral RNA was gradually being 
eliminated.
Idiopathic inflammatory myopathies
Polymyositis (PM) is an inflammatory disease of the 
skeletal muscle.36 It is the m ost frequently acquired 
muscular disease in adults and has a chronic progressive 
character. O nly half of the patients have long lasting 
responses after treatm ent w ith antiinflammatory and 
immunosuppressive drugs. Despite treatment, many 
patients become progressively handicapped. D erm ato­
myositis (DM) affects both adults and children and can be 
identified by a characteristic rash which often precedes 
muscle weakness.37 Muscle weakness, electrom yo­
graphic findings and elevated muscle enzymes are equally 
present in both  inflammatory myopathies.36 Inclusion 
body myositis (IBM) is considered to be a distinct type of 
myositis. IBM presents frequently as polymyositis-like 
disease w ith onset above 50 years and resistance to 
therapy.38
Several findings suggest a relation betw een entero­
viruses and m yopathy. Enterovirus has sporadically been 
isolated from muscle biopsies of patients w ith PM .39'40 
Using electron microscopy, virus-like crystals have been 
detected in muscle tissue,41 but these crystals could have 
been /?-g!y cogen particles.42 It has also been described 
that chronic enterovirus infections in patients with 
agammaglobulinaemia are often associated w ith DM-like 
symptoms.3 However, in contrast to PM  and DM, 
enterovirus can still be isolated in these chronic 
infections.
To investigate the hypothesis that persistence of 
enterovirus is involved in the maintenance of PM, D M  
and IBM, several research groups have used molecular 
hybridisation to  detect the enteroviral genom e in skeletal 
muscle (Table 2). In none of a total of 53 patients with 
IBM, could viral RNA be detected (Table 2). In the case 
of PM  and D M  the results are less consistent. Using 
quantitative slot-blot analysis Bowles et a l43 and 
Cunningham et al.44 dem onstrated enteroviral RNA in a 
significant number of patients. Yousef et a l45 confirmed 
these results for PM  patients w ith ISH. These results were 
not confirmed by Rosenberg et al.,46 using ISH, but this 
group detected a positive signal in 3 of the 9 cases with 
D M  when a probe for Theiler's encephalomyelitis virus (a 
cardiovirus) was used. A  strong sequence hom ology has 
been described betw een cardioviruses and eukaryotic 
enzymes such as tRNA synthetases.50 However, this 
was based on amino acid sequences and it does not
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Table 2. Molecular diagnosis of enteroviral RNA in chronic diseases
Reference Country Method Disease
Number of 
patients
Enteroviral
positive
Bowles et nl.[4>l UK QSB PM 2 1
DM 7 4
Control 10 0
Cunningham et al}4'1' UK QSB PM 46 9
DM 36 14
IBM 24 0
Control 128 0
Yousef et a/.1'15' UK ISH PM 11 6
DM 2 0
Control 13 0
Rosenberg et al.l4c] USA ISH PM 5 0
DM 9 3*
IBM 5 0
Control 14 0
Left et ali47] USA PCR PM 18 0
DM 12 0
IBM 14 0
Control 13 0
Leon-Monzon and Dalakas14*1 USA PCR PM 16 0
DM 12 0
IBM 11 0
Control 16 0
Jongen et nl}4*] NL PCR PM 10 0
DM 5 0
Control 15 0
Gow et al.167' UK PCR PVFS 60 32
Control 41 6
Archard et al}0*1 UK QSB PVFS 96 20
Control 4 0
Cunningham et al}441 UK QSB PVFS 140 34
* Control 152 0
Melchers et alJ70' NL PCR PPS 16 0
Control 7 0
See Table 1; PM. Polymyositis; DM. Dermatomyositis; IBM. Inclusion body myositis: PVFS, Post viral fatigue syndrome; PPS. Post-polio 
syndrome. 'Only positive for TMEV.
necessarily reflect the RNA sequences. O n the other 
hand, however, the positive signal was not detected in 
the muscle fibres itself.46 A lthough PCR is more sensitive 
than slot-blot hybridisation, Leff et al.,47 Leon-M ozon and 
Dalakas,48 and Jongen et al.49 were not able to  dem on­
strate the presence of enteroviral RNA in these patient 
groups. Again, it cannot be excluded that the results 
obtained by slot-blot hybridisation are at least in part due 
to  cross-hybridisation w ith unrelated sequences.28
The m ost widely used animal model for polymyositis 
is the coxackievirus B l induced murine myositis.51 As 
w ith myocarditis, the model resembles the human disease 
in that affected animals develop a chronic myositis in the 
hamstrings. The virus can be isolated from the muscles 
until 14 days p.i.52,53 Beyond this time the virus can no
longer be isolated, although RNA can still be detected by 
molecular hybridisation. Tam et a l52 were only able to 
detect the viral RNA up to  about 28 days p.i. These 
results were confirmed by Zoll et al.53 using PCR. No 
viral RNA could be detected thereafter. Both a myocardi­
tis and a myositis could be induced in mice by a 
m yotropic variant of encephalomyocarditis virus.28 Virus 
could be isolated in high titres at 7 days p.i., but only a 
very low titre was found at 2 weeks p.i., and no virus 
could be isolated thereafter. Using ISH, positive hybrid­
isation was detected in skeletal muscle at 3 weeks but was 
only seldomly found as late as 4 weeks p.i. Similar to the 
coxackievirus B induced murine cardiom yopathy model 
as described above, this suggests that the infection is 
dying out after 4—6 weeks rather than persisting.
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Insulin-dependent diabetes mellitus
Insulin-dependent diabetes mellitus (IDDM) is the result 
of a progressive destruction of pancreatic jS-cells.54 It is 
considered to  be an autoimmune disease in which, apart 
from genetic factors, environmental factors such as virus 
infections m ight play a role.54
The association w ith enterovirus (Coxsackie B) is 
suspected on the basis of several findings. Case reports 
have described the developm ent of diabetes mellitus, 
shortly after an infection w ith Coxsackie B virus,55 and 
epidemiological studies showed that IgM  antibodies were 
found more frequently in patients w ith diabetes mellitus 
than in control groups.56'57 A  possible role of the virus in 
the destruction of the pancreatic jS-cells remains unclear. 
The viral infection may trigger a /?-cell specific autoim ­
mune response. A nother possibility is that the viruses 
infect the insulin-producing (3-cells and persist in these 
cells. However, a viral infection is only found rarely at 
the mom ent IDDM  is diagnosed. In none of the 88 
autopsy pancreases from patients who died of diabetes 
mellitus, could V P l antigens be detected.58 However, this 
cannot be regarded as evidence against the hypothesis of 
enteroviral persistence, since V P l m ight not be expressed 
during the persistence of viral RNA. In fact, Kuge et al.59 
reported that deletions in the genomes of DI particles 
derived from the Sabin strain of poliovirus type I, were 
limited to  the internal genome region encoding the viral 
capsid proteins. These facts do not exclude an aetiologi- 
cal role for viruses, but a possible relationship m ust be 
complex.
Recently, a model has been described in which infec­
tion of mice w ith coxsackievirus B4 led to  a chronic 
infection of the pancreas.60 The virus titres in the 
pancreases were low, and the animals had a continuing 
humoral immune response, but infectious virus could still 
be isolated for up to  10 months. However, these experi­
ments were performed with a pancreas adapted variant of 
coxsackievirus B4 which suppresses M HC class I expres­
sion. O n the other hand, this again reflects a chronic 
productive infection in which the virus could be isolated 
at any time of the infection and is therefore different from 
latency as supposed by the single finding of viral RNA.
O n the basis of the data described so far, possible 
enteroviral RNA persistence can no t be excluded, but it 
has certainly not been proven.
Post-viral fatigue syndrome
The post-viral fatigue syndrome (PVFS) is considered to 
be a distinct form of the chronic fatigue syndrome, with 
onset after a flu-like episode with fever which is believed 
to be of viral origin.61'62 PVFS is characterised by an 
excessive disabling fatigue which persists for more than 6 
m onths.44 The fatigue is accompanied by diverse physical 
complaints.44 A relationship w ith enteroviruses is sus­
pected mainly on (sero)epidemiological findings. High 
levels of neutralising antibody against Coxsackie B 
viruses were found in 50% of the PVFS patients as 
compared with 17% of healthy controls.63 M cCartney et 
al.64 detected Coxsackie B virus specific IgM  in 31% of 
the patients. Because virus specific IgM  responses were
detected in consecutive sera from several PVFS patients 
for a year or even longer, it was suggested that this is 
indicative for viral persistence rather than a recent 
infection.64 Further indication for viral persistence was 
reported by Yousef et al.,65 who found infectious 
enterovirus in faecal specimens of about 20% of the 
patients w ith PVFS after dissociation of immune com­
plexes, whereas direct virus isolation failed. A  few groups 
have used molecular detection to  investigate whether 
enteroviral RNA is present in skeletal muscle of PVFS 
patients (Table 2). Using quantitative slot-blot hybridis­
ation, Archard et al.66 and Cunningham et al,44 found 
approximately 25% of the muscle biopsy samples posi­
tive for enteroviral RNA. N one of the controls was 
positive. G ow  et al.,67 using PCR, confirmed these data 
and found 53% of the patients positive for enteroviral 
RNA. However, they also found 15% of the controls 
positive for enteroviral RNA, which is highly excep­
tional. Based on these results the authors suggested 
that enteroviral persistence may play a role in the 
pathogenesis of the PVFS.44,66,67
However, before it can be stated that enterovirus 
indeed can persist in muscle from patients w ith the PVFS, 
these results should be confirmed by other groups. All 
studies on molecular detection of enteroviral RNA in 
PVFS were performed in patients from the UK, and may 
reflect a particular approach of selecting patients, a 
geographical difference, or technical aspects of entero­
virus detection. Therefore it would be interesting to 
compare data from the UK systematically with those of 
other countries, as can be done for idiopathic inflamma­
tory  myopathies, in which, from the limited data avail­
able, enteroviral RNA was only detected in muscle 
biopsies of patients from the UK.
Post-polio syndrome
As is the case w ith the diseases discussed before, the 
pathogenetic mechanism underlying the post-polio syn­
drome (PPS) is no t understood. The syndrom e manifests 
itself about 30 years after an attack of paralytic polio­
myelitis and a relationship with the previous poliovirus 
infection is suspected.68 An association with poliovirus 
persistence was suspected because intrathecal synthesis of 
IgM  antibodies to  poliovirus was found in patients with 
PPS.69 However, these findings could no t be confirmed. 
Using PCR, we and others failed to  detect poliovirus 
RNA in muscle samples and cerebrospinal fluid from 
patients with the PPS.48,70 N either could we detect 
poliovirus specific IgM  antibody in the cerebrospinal fluid 
of these patients. The basis for possible enteroviral 
persistence is very small but as long as no brains and 
peripheral nervous tissues have been investigated, 
persistence can not absolutely be excluded.
CO NCLUDING  REMARKS
Viral persistence can be divided into chronic productive 
infections, in which infectious virus is present and can be
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recovered by conventional methods, and into latent 
infections. In the latter, the viral genom e is present but 
infectious vims is generally not produced except during 
intermittent episodes of reactivation.71 Persistent 
enterovirus infections in neonates or patients w ith agam- 
maglobulinaemia are of the chronic productive type. 
Enteroviral persistence, as is supposed to  occur in the 
chronic diseases IDC, PM /DM , IDDM, PVFS and PPS, is 
more difficult to classify. These infections m ight be 
considered to be latent since the viral RNA is detected 
while the virus cannot be isolated.
In the mouse models of IDC and PM /D M  the viral 
RNA can be detected for about 4 weeks p.i. Since virus 
can be isolated for 2 weeks p.i., this means that the virus 
'persists' only for 2 additional weeks. It is furthermore 
difficult to envisage how  the viral RNA could be main­
tained in a cell w ithout expression of viral products, 
which so far has no t been experimentally described in the 
'persistent' state of infection. Hence, the hypothesis of 
enteroviral persistence is not well founded.
As mentioned before, enteroviruses cause a lytic infec­
tion. The infection is controlled by the immune system 
which will become active within 5—7 days. For reasons 
which are not fully understood the lytic infection can 
slow dow n to  a chronic productive one w ith little or no 
cell lysis, as has been dem onstrated in vitro72'73 So it may 
be that the virus can be trapped in a few cells that, 
probably because of defective virus replication, do not 
immediately lyse. Several reports have described an 
abnormal production of equal amounts of positive and 
negative strands of enteroviral RNA in patients with the 
PVFS as well as in coxsackievirus B3 induced myocarditis 
in the mouse.32'74'75 This double-stranded RNA inter­
mediate is very stable and not as sensitive to  RNase 
degradation as the single-stranded viral genome. The 
presence of a 1:1 molar ratio of the ( +  ) and ( — ) strand 
RNA implies that all ( +  ) strand viral genomes are 
captured in a highly stable complex, so that further 
production of infectious virus will be prevented. The 
RNA will eventually be eliminated. In the murine models 
this occurs within 4 weeks, in the human situation 
probably after a long period of time. This means that the 
infection is dying out.
The literature concerning the presence of enteroviral 
RNA in humans is conflicting (see Tables 1 and 2). Part 
of the controversy may be explained by sampling 
errors or the unreliability of conventional hybridisation 
assays as slot-blot hybridisation.24'28'48 It would be 
convincing if enteroviral antigens were also found, and 
if repeated biopsies were tested to follow persistence in 
time.
Does this all mean there is no place for enteroviruses 
in the pathogenesis of the human chronic diseases? There 
is still evidence for a relationship, which is also supported 
by the murine models. It only implies that a sustained 
presence of the viral RNA in the affected tissues may not 
be essential. Post infectious auto-immunity has been 
postulated by many investigators and remains an im port­
ant issue to be studied.11'76'77 From such studies in the 
murine cardiomyositis model it became clear that anti­
heart antibody is generated in the myocarditic mouse,11 
that autoreactive cytotoxic T lymphocytes that can cause 
cardiac damage after adoptive transfer to  uninfected mice 
are generated as well.77 In addition, several epitopes 
have been described that show cross reactivity between 
Coxsackie B viruses and cardiac myocytes (molecular 
mimicry).11'12 The strain of Coxsackie B virus used, as 
well as genetic factors of the host, are found to  be of 
crucial importance. W hat makes a strain myocarditic or 
no t is still poorly understood. The difference m ight reside 
in the type of immune response m ounted by the various 
strains.78 In this paper, the present literature concerning 
persistence of enteroviruses as a cause for the develop­
ment of human disease was reviewed, and we conclude 
that there is no clear evidence for enteroviral RNA 
persistence and the subsequent developm ent and 
maintenance of chronic medical conditions in humans.
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